DOH Central Pharmacy – FDA 483, Jul 28, 2025
An FDA inspection of DOH Central Pharmacy, a unit dose repacker in Tallahassee, FL, revealed significant deficiencies across multiple quality systems. Observations included inadequate quality control unit procedures, lack of equipment cleaning validations and proper record-keeping, unsupported expiration dates for repackaged drugs, and insufficient sampling of components and complaint handling. These issues indicate a need for comprehensive improvements in the firm's manufacturing and quality assurance practices.
- Office
- Florida District Office
- Person
ID · 2e63bbe8-378e-4bfb-9291-b4cd93a9a372
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.